Aprepitant

FDA Approved: * September 24, 2012
Pharm Company: * SANDOZ
Category: Nausea & Vomiting

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Aprepitant Overview

Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting.[1] It may be used together with ondansetron and dexamethasone.[1] It is taken by mouth.[1] Common side effects include tiredness, loss of appetite, diarrhea, abdominal pain, hiccups, itchiness, pneumonia, and blood pressure changes.[1] Other sev...

Read more Aprepitant Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Aprepitant

Recent Aprepitant Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

NDC Database Records for Aprepitant: (8 results)

Sorted by National Drug Code

• 0781-2321 Aprepitant 40 mg Oral Capsule by Sandoz Inc
• 0781-2322 Aprepitant 80 mg Oral Capsule by Sandoz Inc
• 0781-2323 Aprepitant 125 mg Oral Capsule by Sandoz Inc
• 0781-4063 Aprepitant Kit by Sandoz Inc
• 68462-112 Aprepitant Kit by Glenmark Pharmaceuticals Inc., USA
• 68462-583 Aprepitant 40 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA
• 68462-584 Aprepitant 80 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA
• 68462-585 Aprepitant 125 mg Oral Capsule by Glenmark Pharmaceuticals Inc., USA

Other drugs which contain Aprepitant or a similar ingredient: (4 results)

• CINVANTI Aprepitant
• EMEND Aprepitant1 discussion
• FOSAPREPITANT
• IVEMEND Fosaprepitant Dimeglumine

Related Aprepitant Topics: